Location History:
- Valhalla, NY (US) (1989 - 1991)
- New York, NY (US) (1994)
Company Filing History:
Years Active: 1989-1994
Title: Innovations in Glaucoma Research by Bernard I. Weinstein
Introduction
Bernard I. Weinstein, an inventive force in the field of ophthalmology, is based in Valhalla, NY, and has made significant contributions through his patented technologies aimed at better understanding and treating glaucoma. With three notable patents to his name, Weinstein continues to push the boundaries of innovation in medical science.
Latest Patents
Weinstein's latest patents reflect his commitment to advancing glaucoma diagnostics and therapeutics. One of his notable inventions is an assay for determining patients either having Primary Open Angle Glaucoma or those at risk of developing this condition. This assay focuses on testing cells, particularly lymphocyte cells, for reduced 3-alpha-hydroxysteroid dehydrogenase (3-alpha-HSD) activity. By evaluating the level of this activity, healthcare providers can ascertain whether a patient is either suffering from or at risk of developing Primary Open Angle Glaucoma.
Another significant patent is centered around utilizing tetrahydrocortisol in glaucoma therapy. Weinstein's invention encompasses pharmaceutical compositions containing tetrahydrocortisol and methods to use these formulations for effectively controlling intraocular pressure, a critical parameter in the management of glaucoma.
Career Highlights
Bernard I. Weinstein is associated with the New York Medical College, where he applies his expertise in ophthalmology to research and develop innovative treatments for glaucoma. His career is marked by a dedication to enhancing patient care through scientific inquiry and invention.
Collaborations
Throughout his career, Weinstein has collaborated with esteemed colleagues, including Gary G. Gordon and Aaron L. Southren. Together, they have contributed to the collective knowledge and therapeutic approaches in the field of ophthalmology, advancing the understanding of glaucoma and its treatment.
Conclusion
Bernard I. Weinstein exemplifies the spirit of innovation in the medical field, particularly in glaucoma research and treatment. His work not only highlights the importance of patient diagnostics but also offers promising therapeutic avenues for managing intraocular pressure. Through his patents and collaborations, Weinstein continues to make strides that could greatly benefit those affected by glaucoma.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.